NCT00080899 2015-03-06Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerNational Cancer Institute (NCI)Phase 2 Completed23 enrolled 3 charts
NCT00077402 2013-05-15Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate CancerNational Cancer Institute (NCI)Phase 2 Completed50 enrolled